Last reviewed · How we verify
NCT07368114
Validity of Ozonated Olive Oil Gel Versus Injectable Bone Graft
Phase 2 trial testing Immediate implant placement in Dental in 16 participants. Completed in 10 September 2025.
10 May 2025
Quick facts
| Lead sponsor | Suez Canal University |
|---|---|
| Phase | Phase 2 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 16 |
| Start date | 10 December 2023 |
| Primary completion | 10 May 2025 |
| Estimated completion | 10 September 2025 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Immediate implant placement
- β-tricalcium phosphate Injectable Bone Graft — full drug profile →
- Ozonated olive oil gel — full drug profile →
Conditions studied
- Dental — all drugs for Dental →
- Implant Osseointegration — all drugs for Implant Osseointegration →
- Ozone Therapy — all drugs for Ozone Therapy →
- Bone Graft — all drugs for Bone Graft →
Sponsor
Suez Canal University
Who can join
Adults 20 to 60, any sex, with Dental or Implant Osseointegration. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Many of studies have been performed to improve osseointegration and bone density around implants by modifying the implant by adding bone graft or substitute material that increase success of implant. The aim of this study is to evaluate clinically and radiographically the efficacy of injectable bone graft versus ozonated olive oil gel to promote bone formation and improve outcomes in immediate implant cases. 16 immediate implants will be placed in mandibular premolar region the study will be devided equally and randomlly into two groups , Group 1: it will be 8 immediate implants represent the control group were the implants will be placed with injectable bone graft , Group 2: will be 8 immediate implant represent the study group were the implants will be placed with ozonated olive oil gel be used as a graft material . The implant stability will be assessed clinically using Ostell , and the bone density will be assed radiographically .
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07368114
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Immediate implant placement
Trials testing the same drug.
- NCT07080710 — State of the Art Immediate Implant Placement in the Premaxilla · NA · recruiting
- NCT06985511 — Assessment of Marginal Bone Loss and Anterior Implant Stability in Immediate Versus Early Implant Placement · NA · completed
- NCT03594019 — Immediate Implant Placement With Connective Tissue Graft or Socket Shield · Phase 3 · unknown
- NCT04160247 — Angulated Screw-retained Crowns Following Immediate Implant Placement · Phase 3 · completed
Other recruiting trials for Dental
Currently open trials in the same condition.
- NCT07459374 — Evaluating Universal Adhesives in Cervical Lesions · NA · active not recruiting
- NCT07083453 — Financial Incentives to Encourage Uptake of Preventive Dental Care Services Among Adults · NA · active not recruiting
- NCT06403839 — Impact of Preoperative Dental Screening in Reducing Infective Endocarditis Risk in Surgical Valve Replacement Patients · recruiting
Other Suez Canal University trials
Trials by the same sponsor.
- NCT07263893 — Inter Flex Three Dimensional Plate in Management of Mandibular Fracture RCT · NA · recruiting
- NCT07280533 — Accuracy of Virtual Surgical Planning Versus Traditional Technique in Zygomaticomaxillary Fracture Reduction · NA · not yet recruiting
- NCT07291791 — tDCS for Pain Modulation in Knee Osteoarthritis · NA · active not recruiting
- NCT07262086 — Clinical Evaluation of Wear Resistance and Bioactivity of Self Cured Bioactive Resin Composite · NA · enrolling by invitation
- NCT07125846 — Efficacy of Bioactive Glass vs. Xenograft in Maxillary Sinus Augmentation · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07368114 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Suez Canal University
- Last refreshed: 26 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07368114.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing